Program

96
61
10
2
2

Journal Year Published

2
18
12
19
9
15
13
13
7
3
10
7
4
2

Author

134
182
174
134
125
118
116
114
108
88
86
81
73
56
51
50
43
43
42
34

Category

73
51
39
15
7
5
4
3
1
1

Keyword

59
33
24
22
19
16
15
14
12
12
11
11
10
9
9
9
9
8
8
8

Journal

13
9
5
5
5
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2

NCATS Publications

Inhibition of PIP4Kγ ameliorates the pathological effects of mutant huntingtin protein.


Al-Ramahi I, Panapakkam Giridharan SS, Chen Y, Patnaik S, Safren N, Hasegawa J, de Haro M, Wagner Gee AK, Titus SA, Jeong H, Clarke J, Krainc D, Zheng W, Irvine RF, Barmada S, Ferrer-Alegre M, Southall N, Weisman LS, Botas J, Marugan JJ


Elife , (6), 2017.

Article Pubmed

Sample image from publication page

Repurposing a novel parathyroid hormone analogue to treat hypoparathyroidism.


Krishnan V, Ma YL, Chen C, Thorne N, Bullock H, Tawa G, Javella-Cauley C, Chu S, Li W, Kohn W, Adrian MD, Benson C, Liu L, Sato M, Zheng W, Pilon A, Yang N, Bryant HU


Br. J. Pharmacol. , 2017.

Article Pubmed

Sample image from publication page

Drug discovery and development for rare genetic disorders.


Sun W, Zheng W, Simeonov A


Am. J. Med. Genet. A , (173), 2307-2322, 2017.

Article Pubmed

Sample image from publication page

Development of an Aryloxazole Class of Hepatitis C Virus Inhibitors Targeting the Entry Stage of the Viral Replication Cycle.


He S, Li K, Lin B, Hu Z, Xiao J, Hu X, Wang A, Xu X, Ferrer-Alegre M, Southall N, Zheng W, Aubé J, Schoenen FJ, Marugan J, Liang TJ, Frankowski KJ


J. Med. Chem. , (60), 6364-6383, 2017.

Article Pubmed

Sample image from publication page